Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jul 10, 2026

Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection

Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection

Published on: February 7, 2025

Robotic surgery for gastrointestinal malignancies.

C Anderson¹, M Hellan, K Kernstine

¹Department of General and Oncologic Surgery, City of Hope, Duarte, CA, USA.

The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS

|October 24, 2007

Summary

Robotic-assisted surgery is safe and feasible for gastrointestinal (GI) cancer operations. This initial study of 73 procedures shows promising results for radical oncological surgeries.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Validation of an endoscopic anastomotic grading score as an intraoperative method for assessing stapled rectal anastomoses.

Techniques in coloproctology·2023

Same author

Analysis of delay in adjuvant chemotherapy in locally advanced rectal cancer.

Techniques in coloproctology·2022

Same author

Assessing the effectiveness of laser fistulectomy for anal fistula: a retrospective cohort study.

Techniques in coloproctology·2020

Same author

Totally intracorporeal robotic en bloc resection for deep infiltrating endometriosis of the rectovaginal wall with natural orifice specimen extraction.

Techniques in coloproctology·2019

Same author

Robotic ventral mesh rectopexy for rectal prolapse: a single-institution experience.

Techniques in coloproctology·2017

Same author

Combined transanal total mesorectal excision (taTME) with laparoscopic instruments and abdominal robotic surgery in rectal cancer.

Techniques in coloproctology·2017

Area of Science:

Surgical Oncology
Minimally Invasive Surgery
Robotic Surgery

Background:

Robotic-assisted surgery is increasingly explored for treating gastrointestinal (GI) malignancies.
This report details the initial experience with robotic procedures for GI cancers.

Purpose of the Study:

To evaluate the safety and feasibility of robotic-assisted surgery for GI cancer treatment.
To assess outcomes of robotic procedures for oesophageal, gastric, and rectal resections.

Main Methods:

Retrospective review of 73 robotic procedures for GI cancer performed between November 2004 and July 2007.
Procedures included oesophagectomies, gastrectomies, and rectal resections.
Analysis of operative times, postoperative morbidity, leak rates, length of stay, lymph node yield, and follow-up data.

More Related Videos

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jul 10, 2026

Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection

Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection

Published on: February 7, 2025

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib

Published on: April 3, 2026

Main Results:

Median operative times varied by procedure: rectal (285 min), gastric (430 min), and oesophageal (482 min).
Major postoperative morbidity rates were 16% (rectal), 9% (gastric), and 32% (oesophageal).
Leak rates ranged from 9% to 16%, with a median follow-up of 9 months and zero 30-day mortality.

Conclusions:

Robotic-assisted surgery appears safe and feasible for various radical oncological GI procedures.
Initial outcomes suggest potential benefits in specific surgical contexts.
Further research is warranted to fully establish the role of robotic surgery in GI oncology.